Clinical trials recruiting in Yulin, China
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 3Phase 3 3Not applicable 2
Conditions recruiting in Yulin, China
Recruiting trials in Yulin, China
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
- Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Mobile Applet for Weight Management in Obese Heart Failure Patients
- Phase II Study of RC1416 Injection in COPD
- Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
- The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
Common questions
How many clinical trials are recruiting in Yulin, China?
8 recruiting trials have at least one study site in Yulin, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.